Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01478256 · ClinicalTrials.gov registry record · Phase 4
Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis
A Phase 4 study of Blepharitis, sponsored by John, George, M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01478256: Completed Phase 4 study of Blepharitis, sponsored by John, George, M.D..
NCT01478256 is a Phase 4 study of Blepharitis that has completed, run by John, George, M.D.. The registered enrollment target is 30 participants, below the 55-participant average among 6 other Blepharitis trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01478256, a Phase 4 study of Blepharitis, has completed, sponsored by John, George, M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study looks at the improvements in signs and symptoms in patients with inflammation of the lids, blepharitis, using two different FDA approved topical antibiotic agents, Besifloxocin and Erythromycin. It also evaluates the bacterial cultures in these patients for microbiologic evidence of improvement.
Primary Outcome
Signs and symptoms of blepharitis were scored and determined before and after treatment with two different antibiotics
Conditions Studied
Interventions
- DRUG Erythromycin
- DRUG Besifloxocin
Study Locations (1)
Kentucky
- George John, M.D. - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-10 |
| Phase | Phase 4 |
What the finished NCT01478256 record still lists
NCT01478256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 55-participant average among 6 other Blepharitis trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Blepharitis appearing as the primary indexed condition, and to 2 interventions - of which Erythromycin is the first listed.
NCT01478256 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT01478256 about?
NCT01478256 is a clinical study titled "Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis". This study looks at the improvements in signs and symptoms in patients with inflammation of the lids, blepharitis, using two different FDA approved topical antibiotic agents, Besifloxocin and Erythromycin. It also evaluates the bacterial cultures in these patients for microbiologic evidence of impro...
What is the current status of trial NCT01478256?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2011-08. Estimated completion is 2011-10.
What conditions does trial NCT01478256 study?
This clinical trial studies the following conditions: Blepharitis.
What interventions are being tested in trial NCT01478256?
The interventions under investigation include: Erythromycin (DRUG), Besifloxocin (DRUG).
Who is sponsoring clinical trial NCT01478256?
This trial is sponsored by John, George, M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01478256 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blepharitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis
COMPLETED · Phase 4
-
Evaluation of SUMMIT BRUSH in Treatment of Blepharitis
RECRUITING · NA
-
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex
ACTIVE NOT RECRUITING · Phase 2
-
Corneal Epithelial Stem Cells and Dry Eye Disease
COMPLETED · NA
-
A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis
COMPLETED · Phase 3
-
Treatment of Patients With Blepharitis and Facial Rosacea
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia